UBS AM’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Buy |
|
|||||
|
2025
Q1 | $790K | Buy |
|
|||||
|
2024
Q4 | $958K | Buy |
|
|||||
|
2024
Q3 | $1.58M | Buy |
|
|||||
|
2024
Q2 | $1.37M | Sell |
|
|||||
|
2024
Q1 | $4.63M | Sell |
|
|||||
|
2023
Q4 | $9.27M | Sell |
|
|||||
|
2023
Q3 | $7.28M | Sell |
|
|||||
|
2023
Q2 | $14.6M | Hold |
|
|||||
|
2023
Q1 | $14.6M | Buy |
|
|||||
|
2022
Q4 | $12.2M | Sell |
|
|||||
|
2022
Q3 | $18.6M | Buy |
|
|||||
|
2022
Q2 | $13.1M | Buy |
|
|||||
|
2022
Q1 | $17.2M | Sell |
|
|||||
|
2021
Q4 | $18.9M | Buy |
|
|||||
|
2021
Q3 | $7.39M | Sell |
|
|||||
|
2021
Q2 | $9.6M | Sell |
|
|||||
|
2021
Q1 | $14.7M | Sell |
|
|||||
|
2020
Q4 | $20.1M | Buy |
|
|||||
|
2020
Q3 | $10.8M | Buy |
|